Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Medical Genetics 1999;36:21-27; doi:10.1136/jmg.36.1.21
Copyright © 1999 by the BMJ Publishing Group Ltd.
J Med Genet 1999;36:21-27 ( January )

Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome)

Peining Lia, Amy B Bellowsa, Jerry N Thompsona b

a Laboratory of Medical Genetics, University of Alabama at Birmingham, 420 Sparks Center, 1720 7th Avenue South, Birmingham, AL 35294, USA, b Departments of Biochemistry and Molecular Genetics, and Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35294, USA

Correspondence to: Dr Thompson.

Received 3 March 1998; Revised version accepted for publication 17 June 1998

Mucopolysaccharidosis type II (Hunter syndrome) is an X linked lysosomal storage disorder resulting from heterogeneous mutations in the iduronate-2-sulphatase (IDS) gene. To detect IDS gene mutations, direct sequencing of IDS cDNA fragments coupled with assays on IDS genomic amplicons was applied to 18 unrelated patients with MPS II. Seventeen mutations were detected from the 18 patients including seven missense mutations (S71R, A82E, A85T, R88C, R468W, R468Q, and E521V), five deletions (Delta R95, 383delAT, 596delAACA, 1148delC, and 1216delCT), two insertions (208insC and 1063insA), two splicing mutations (1006+5gright-arrowc in intron 7, 1122Cright-arrowT in exon 8), and an intragenic deletion of IDS exons 4, 5, 6, and 7. Nine of the small mutations were novel mutations. Mutation 596delAACA was detected in two unrelated patients. The mutation in intron 7 was found to cause aberrant splicing and resulted in a 22 bp insertion into its mRNA transcript. The intragenic deleted IDS gene expressed two aberrant mRNA transcripts consisting of exons 1-2-8-9 and 3-8-9. Analysis of mutations A85T, R88C, R468Q, R468W, and 438C/T found no polymorphism for the four missense mutations but about 36% heterozygosity for the 438C/T silent mutation. These results provide further evidence of mutational heterogeneity for MPS II. Also, underlying sequence directed mutagenesis mechanisms for some recurrent mutations in the IDS gene were proposed.


Keywords: mucopolysaccharidosis type II; Hunter syndrome; iduronate-2-sulphatase gene; mutation detection


© 1999 by J Med Genet

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Martin, R., Beck, M., Eng, C., Giugliani, R., Harmatz, P., Munoz, V., Muenzer, J. (2008). Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome). Pediatrics 121: e377-e386 [Abstract] [Full Text]  
  • Roeser, D., Preusser-Kunze, A., Schmidt, B., Gasow, K., Wittmann, J. G., Dierks, T., von Figura, K., Rudolph, M. G. (2006). A general binding mechanism for all human sulfatases by the formylglycine-generating enzyme. Proc. Natl. Acad. Sci. USA 103: 81-86 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Genetics jobs

Genetics jobs